Cereno Scientific participates at the 19th Global CVCT Forum 2022 discussing clinical trials in cardiovascular disease with top thought leaders
Cereno Scientific (XSAT: CRNO B) today announced the company will participate at the 19th Global CVCT Forum 2022 on December 1-3, 2022, in Washington D.C., US. The Global Cardiovascular Clinical Trialists (CVCT) Forum brings together the top thought leaders in cardiovascular disease and is co-chaired by Dr Bertram Pitt and Dr Faiez Zannad, both part of Cereno’s Scientific Advisory Board. Cereno’s Chief Medical Officer (CMO), Dr Björn Dahlöf, is invited to speak and participate in several program sessions providing an industry perspective on significant topics such as patient benefit, clinical